Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: Lynne.Nichols@dhsc.gov.uk
NUTS: UK
Internet address(es)
Main address: https://dh.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Contract for the Supply of Lopinavir/Ritonavir Tablets
Reference number: CM/EMP/20/1417/350
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
A requirement for the supply of lopinavir/ritonavir tablets.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
32 857.55
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Movianto, Haydock.
II.2.4) Description of the procurement
A requirement to secure lopinavir/ritonavir tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
Extreme urgency brought about by events unforeseeable for the contracting authority and in accordance with the strict conditions stated in the Directive
Explanation
A situation of extreme urgency exists both in the UK and across the World, in the context of the spread of Covid-19. Lopinavir/ritonavir tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply lopinavir/ritonavir tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the lopinavir/ritonavir tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of lopinavir/ritonavir tablets.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
18/03/2020
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
AbbVie Ltd
Maidenhead
UK
NUTS: UKJ1
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 32 857.55
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The contracts is for the benefit of the authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 2 March 2020.
VI.4) Procedures for review
VI.4.1) Review body
The High Court
Strand
London
UK
VI.5) Date of dispatch of this notice
27/04/2020